| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |